Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Can-Fite Presented NASH Phase II Namodenoson Data at a Late Breaking Session of AASLD Conference
Can-Fite to Present its NASH Program in Fireside Chat at the H.C. Wainwright 6th Annual Israel Conference on November 12, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 14) * 10X Genomics Inc (NASDAQ: TXG) * Aileron Therapeutics Inc (NASDAQ: ALRN) * Amicus Therapeutics, Inc. (NASDAQ: FOLD) * Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO) * Blueprint Medicines Corp (NASDAQ: BPMC) * Calliditas Therapeutics Adr Rep 2 Ord Shs (NASDAQ: CALT) * Cellectis SA (NASDAQ: CLLS) * Crispr Therapeutics AG (NASDAQ: C...
Can-Fite to Host Conference Call to Update Shareholders on Positive Interim Results of its Phase III Psoriasis Study on October 15, 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced that the Independent Data Monitoring Committee (IDMC) which conducted an interim analysis of the Company’s Phase III Comfort™ trial of Piclidenoson in the treatment of moderate-to-severe plaque psoriasis, recommended, based on the positive data, to continue the study with the original samp...
Can-Fite Selected to Deliver Late-Breaking Presentation on Namodenoson’s Treatment of NASH at American Association for the Study of Liver Diseases
Can-Fite to Participate in Two BioPharma Partnering Conferences
Can-Fite to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020